HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Therapeutic and Adverse Effects of Thrombomodulin Alfa to Treat Sepsis-Induced Disseminated Intravascular Coagulation.

Abstract
In the treatment of disseminated intravascular coagulation (DIC), which is a complication of underlying diseases such as infections and malignant tumors, effective plasma concentrations of thrombomodulin (TM) alfa range from 300 to 900 ng/mL; however, appropriate concentrations when treating sepsis-induced DIC are unknown. Thus, our aim was to determine the relationship between plasma concentrations of TM alfa and its therapeutic effects, and hemorrhagic adverse events. First, we calculated the plasma trough concentrations of TM alfa in septic DIC patients. Next, we divided patients into two groups according to their plasma concentrations into a low- and high-concentration group based on a cut-off value of 600 ng/mL. Fourteen and 35 patients were included in the low- and high-concentration groups, respectively. The Japanese Association for Acute Medicine DIC diagnostic criteria score 4 days after TM alfa administration decreased significantly by 2.06 points from baseline in the high-concentration group compared with 0.71 points in the low-concentration group. The 90-day survival rate was significantly higher in the high-concentration group (85.4%) than in the low-concentration group (49.0%) (hazard ratio, 0.27; 95% confidence interval: 0.09-0.86). In contrast, the incidence of serious hemorrhage was not significantly different between the groups. The recommended plasma concentration of TM alfa in the treatment of septic DIC was determined to be higher than 600 ng/mL, and a dose of 380 U/kg (0.06 mg/kg) was necessary to achieve this concentration.
AuthorsMasaharu Imaura, Miki Tsumori, Satoshi Nagase, Kazuya Omura, Hiroyuki Takahashi, Saori Hatoyama-Tanaka, Fumihiko Katagiri, Risa Takayanagi, Hiroshi Kanno, Yasuhiko Yamada
JournalShock (Augusta, Ga.) (Shock) Vol. 54 Issue 1 Pg. 50-55 (07 2020) ISSN: 1540-0514 [Electronic] United States
PMID31764622 (Publication Type: Journal Article)
Chemical References
  • Thrombomodulin
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Disseminated Intravascular Coagulation (blood, drug therapy, etiology, mortality)
  • Female
  • Hemorrhage (chemically induced)
  • Humans
  • Kaplan-Meier Estimate
  • Male
  • Middle Aged
  • Sepsis (complications)
  • Survival Analysis
  • Thrombomodulin (blood, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: